1 Product identity
Ingredient risk
2 ingredients to use with caution
Joint Collagen Plus 1000 mg
BrandConfidence USA→Other Combinations Tablet or Pill 9 ingredients 2 caution DSLD #283353Net contents: 90 Easy Swallow Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2023-03-22
2 Ingredients (9)
IngredientGroupSafety
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Collagen Peptides 🇯🇵 — d health claims. Classified as a food supplement (novel food category in some jurisdictions) [2]. || Japan (MHLW) :: Col
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Collagen Peptides — Use with Caution
Hyaluronic Acid — Generally Safe
⚠ Generally well tolerated
⚠ Theoretical concern in active cancer (promotes angiogenesis)
Grape Seed Extract — Limited Evidence
⚠ Antiplatelet effect
⚠ May interact with anticoagulants
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID283353
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2023-03-22
6 More from Confidence USA
View Confidence USA Safety Scorecard → 3 products
Mil-Gel Chewable TabletsMil-Gel Softgels7 Cite this page
Vancouver
Pkhakadze G. Joint Collagen Plus 1000 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 21]. Available from: https://supplement.ge/products/dsld-283353/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG